Latest Breaking News On - How will the - Page 8 : comparemela.com

  Covid-19 Vaccine stocks – which includes U.S.-listed pharma and biotech companies. The theme is up by about 640% year-to-date versus about 13% for the S&P 500. [Updated 11/11/2020] Why Pfizer’s Vaccine Data Is Good News For Moderna While Pfizer‘s (NYSE: PFE) surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn’t mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong data from the vaccine – which is developed using messenger RNA (mRNA) technology could actually mean a lot more for Moderna (NASDAQ: MRNA), another Covid-19 vaccine player, whose entire drug pipeline is based on mRNA technology.

New yorkUnited statesNew hampshireSouth africaSouth africanModerna covidLonza groupNew york timesEuropean unionHas moderna stock ralliedWhile modernaHow will theImpact modernaLook at modernaPipeline beyond the covid vaccineAdmitting mistake